Google Seeks EPA Permit for 64 Million Wolbachia Mosquitoes in Florida and California
Updated
Updated · en.clickpetroleoegas.com.br · Jun 30
Google Seeks EPA Permit for 64 Million Wolbachia Mosquitoes in Florida and California
3 articles · Updated · en.clickpetroleoegas.com.br · Jun 30
Summary
Google has asked the EPA for an experimental permit to release up to 64 million male Culex quinquefasciatus mosquitoes over two years—16 million annually in each of Florida and California.
The males carry Wolbachia wAlbB bacteria and do not bite; when they mate with wild females lacking the same strain, the eggs fail, aiming to shrink populations linked to West Nile virus and St. Louis encephalitis.
The filing remains under review, not approved: the public comment period closed June 5, and the request drew 3,059 comments, with the EPA classifying the product as an experimental biopesticide.
The proposal targets Culex, not Aedes—a key distinction because Culex is tied to West Nile in the U.S., where the CDC says the disease causes about 2,000 diagnosed cases a year.
Earlier Wolbachia trials help explain the interest: a 2018 Fresno study reported 95.5% fewer female Aedes aegypti in treated areas, while Singapore has reported 80% to 90% population cuts.
With 64 million lab-grown mosquitoes set for release, what unintended consequences could ripple through local ecosystems?
Could wild mosquitoes evolve to outsmart Google’s high-tech sterilization, creating a far more resilient pest?
Google’s Debug Project: EPA Reviews Plan to Release 64 Million Wolbachia-Infected Mosquitoes in California and Florida for Disease Control
Overview
Google's Debug project is seeking EPA approval to release up to 16 million Wolbachia-infected male mosquitoes each year in California and Florida, aiming for a total of 64 million over two years. The public was invited to comment on this plan before the EPA makes a decision, which will be formally announced in the Federal Register. This large-scale intervention is designed to control mosquito populations and reduce disease risk, following established scientific methods. The project’s regulatory journey highlights the importance of public input and transparent decision-making in deploying innovative solutions for public health.